Loading clinical trials...
Loading clinical trials...
The goal of this method comparison study is to compare the detection of hrHPV collected using the Teal Wand Self-Collection device to hrHPV detected from HCP (health care provider) cervical collection...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Teal Health, Inc.
NCT05541016 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, and more
NCT07565740 · HPV-positive Oropharyngeal Squamous Cell Carcinoma
NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more
NCT06157151 · Cervical Cancer, HPV-Related Carcinoma, and more
NCT06532279 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, and more
Birmingham OBGYN / Alabama Clinical Therapeutics
Birmingham, Alabama
Planned Parenthood Northern California
San Francisco, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions